Abrika Pharmaceuticals LLLP acquired by Actavis Group
|
|
|
|
Dalshraun 1. 220 Hafnarfjordur. Iceland |
| |
|
|
+354-535-2300 |
|
|
+354-535-2301 |
|
|
www.actavis.com |
|
|
|
|
|
|
engages in the formulation and commercialization of controlled and immediate release products | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|